| Dr John Edmond Pinkstaff, MD | |
|
17472 Creek Xing, College Station, TX 77845-5523 | |
| (409) 256-5817 | |
| Not Available |
| Full Name | Dr John Edmond Pinkstaff |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 20 Years |
| Location | 17472 Creek Xing, College Station, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194894816 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | E-5014 (Arkansas) | Secondary |
| 207P00000X | Emergency Medicine | M6831 (Texas) | Primary |
| Entity Name | John E. Pinkstaff Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568905610 PECOS PAC ID: 9133405913 Enrollment ID: O20170410001477 |
News Archive
Chemists at The Scripps Research Institute have invented the first practical, scalable method for synthesizing jiadifenolide, a plant-derived molecule that may have powerful brain-protecting properties.
This release will explain how these important technologies encourage high utilization rates across multiple service lines, bringing value to hospitals. Reimbursement changes and hospital structure enable technology purchases to generate a sequence of changes throughout service lines and dramatically impact the bottom line.
For kidney disease patients who need to undergo dialysis, one type of treatment is not best for all, according to a study appearing in the January 2009 issue of the Journal of the American Society Nephrology ( JASN ).
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that the company presented an update on its ZYBRESTAT ophthalmology program, including encouraging preclinical data showing that the company's topical formulation achieved target retina/choroid concentrations with minimal systemic exposure.
› Verified 6 days ago
| Entity Name | Caprock Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922409101 PECOS PAC ID: 6305264284 Enrollment ID: O20200909000774 |
News Archive
Chemists at The Scripps Research Institute have invented the first practical, scalable method for synthesizing jiadifenolide, a plant-derived molecule that may have powerful brain-protecting properties.
This release will explain how these important technologies encourage high utilization rates across multiple service lines, bringing value to hospitals. Reimbursement changes and hospital structure enable technology purchases to generate a sequence of changes throughout service lines and dramatically impact the bottom line.
For kidney disease patients who need to undergo dialysis, one type of treatment is not best for all, according to a study appearing in the January 2009 issue of the Journal of the American Society Nephrology ( JASN ).
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that the company presented an update on its ZYBRESTAT ophthalmology program, including encouraging preclinical data showing that the company's topical formulation achieved target retina/choroid concentrations with minimal systemic exposure.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Edmond Pinkstaff, MD 17472 Creek Xing, College Station, TX 77845-5523 Ph: (409) 256-5817 | Dr John Edmond Pinkstaff, MD 17472 Creek Xing, College Station, TX 77845-5523 Ph: (409) 256-5817 |
News Archive
Chemists at The Scripps Research Institute have invented the first practical, scalable method for synthesizing jiadifenolide, a plant-derived molecule that may have powerful brain-protecting properties.
This release will explain how these important technologies encourage high utilization rates across multiple service lines, bringing value to hospitals. Reimbursement changes and hospital structure enable technology purchases to generate a sequence of changes throughout service lines and dramatically impact the bottom line.
For kidney disease patients who need to undergo dialysis, one type of treatment is not best for all, according to a study appearing in the January 2009 issue of the Journal of the American Society Nephrology ( JASN ).
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that the company presented an update on its ZYBRESTAT ophthalmology program, including encouraging preclinical data showing that the company's topical formulation achieved target retina/choroid concentrations with minimal systemic exposure.
› Verified 6 days ago
Dr. Chet Dean Schrader, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 700 Scott And White Dr, College Station, TX 77845 Phone: 979-207-0100 | |
Dr. Kenneth Wilson Conner Iv, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 Scott And White Dr, College Station, TX 77845 Phone: 979-207-0100 Fax: 979-207-2161 | |
Ann Marie Reed, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: Texas A And M University A P Beutel Health Ctr, Tamu 1264, College Station, TX 77843 Phone: 979-458-8272 Fax: 979-458-8352 | |
Dr. Ripal H Patel, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 Scott And White Dr, College Station, TX 77845 Phone: 979-207-0100 | |
Scott Kimball, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1604 Rock Prairie Rd, College Station, TX 77845 Phone: 979-764-5100 | |
Garry Lynn Gore, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1604 Rock Prairie Rd, College Station, TX 77845 Phone: 979-764-5100 | |
Angela Yang Polansky, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 Scott And White Dr, College Station, TX 77845 Phone: 979-207-0100 |